Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Electronic Full NDA Filings Projected By Mid-1999; 14% User Fees Go To IT

Executive Summary

FDA's electronic submissions program will be equipped to accept full NDA submissions by September 1999, FDA reported in its Prescription Drug User Fee Act Information Management Five-Year Plan, released with the PDUFA II Five-Year Plan on July 10.

You may also be interested in...



CDER's Drug-Drug Interaction Database Will Be Functional By 2000

CDER's drug-drug interaction scientific database will be functional two years ahead of schedule, FDA's fiscal 1999 revision to the Prescription Drug User Fee Act Information Management Plan indicates.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel